Contact

Shane Gleghorn

Partner

Read More
Contact

Shane Gleghorn

Partner

Read More

31 May 2019

Taylor Wessing announces another year of record success

In 2018/19 Taylor Wessing achieved continued UK and global revenue growth to highest levels yet. UK profit rose by 10% and profits per partner by 13%.

Taylor Wessing has announced its 2018/19 unaudited financial results, achieving a 9% increase in fee billing and an 8% increase in overall UK revenue to £156.6m, its highest level to date (£144.6m 2017/18). UK profit increased by 10% to £62.6m (£56.8m 2017/18) and in UK profit per equity partner has increased by 13%.

Global revenue grew by 13% to £339.7m (£301.5m 2017/18), the same percentage increase as last year and another record revenue figure for the firm.

UK Managing Partner, Shane Gleghorn, commented: "The results are very pleasing because we have achieved this high level of profitability and record fee income in a year that has seen a substantial increase in investment in our business. The commitment of our people to deliver successful outcomes for our clients is just fantastic and we will continue to invest in a way that enables them to do that.

We increased our fee income across our areas of sector and practice area focus with some standout performances including a surge in corporate technology deals, particularly around digital platforms. We also achieved strong growth in areas such as patents, data and cybersecurity, Private wealth, real estate and employment. Indeed, all of our core areas of legal services performed well."

Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

Product liability & product safety

Katie Chandler recognised in The Lawyer's Hot 100 2024

29 January 2024

by Shane Gleghorn and Katie Chandler

Click here to find out more
UK

Alexandre Silberman’s portrait 'Diena' wins the Taylor Wessing Photo Portrait Prize 2023

9 November 2023

by Shane Gleghorn

Click here to find out more
Life sciences & healthcare

Further recognition for our market-leading work in the life sciences sector

21 September 2023

by multiple authors

Click here to find out more